Benjamin Eberhardt | Director of Business Development
SmartCella

Biologist with 10 years of experience in marketing and product management across cell & gene therapy, biotech and medtech, now focused on technology licensing. Director of Business Development at SmartCella, building partnerships around the Extroducer®, a delivery technology designed to place advanced therapies directly into organs and tissues that are otherwise hard to reach. The Extroducer is a modality-agnostic endovascular catheter with a flexible 33-gauge needle that is intended to exit the vasculature to deliver ATMPs, small molecules and other payloads into heart, liver, kidney, pancreas, CNS and lung tissue. Previously Product Manager at SIRION Biotech and Revvity, where he took care of LentiBOOST®, a lentiviral transduction enhancer technology licensed to CAR-T and cell therapy developers - a hands-on view of the process and CMC realities that shape how cell therapies reach patients. Earlier roles in life science strategy consulting and scientific communications at transQUER. Master's degree in Biology, Technical University of Munich. Particular interest in the administration gap at the end of the ATMP value chain and in the partnering models that close it.